The Antiproliferative Agent MLN944 Preferentially Inhibits Transcription

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-05-0109
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Antioxidant Graphene Oxide Nanoribbon as a Novel Whitening Agent Inhibits Microphthalmia-Associated Transcription Factor-Related Melanogenesis Mechanism

ACS Omega
ChemistryChemical Engineering
2020English

Histidine-Rich Glycoprotein Inhibits the Antiproliferative Effect of Heparin on Smooth Muscle Cells

Journal of Experimental Medicine
MedicineAllergyImmunology
1987English

Post-Translational Incorporation of the Antiproliferative Agent Azatyrosine Into the C-Terminus of Α-Tubulin

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2003English

Synthesis of Quinazolinones Derivatives an Antiproliferative Agent Against Human Lung Carcinoma Cells

European Journal of Chemistry
2017English

The Anti-Neurodegenerative Agent Clioquinol Regulates the Transcription Factor FOXO1a

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2012English

Ancient microRNA Families That Regulate Transcription Factors Are Preferentially Preserved During Plant Radiation

Plant Signaling & Behavior
2016English

A Non-Bacterial Transcription Factor Inhibits Bacterial Transcription by a Multipronged Mechanism

RNA Biology
Cell BiologyMolecular Biology
2013English

Cellular Repressor Inhibits Human Cytomegalovirus Transcription From the UL127 Promoter

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2004English

The Antipsychotic Agent Sertindole Exhibited Antiproliferative Activities by Inhibiting the STAT3 Signaling Pathway in Human Gastric Cancer Cells

Journal of Cancer
Oncology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy